Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

862 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndrome.
Yanada M, Huang X, Garcia-Manero G, O'brien S, Ravandi F, Borthakur G, Faderl S, Issa JP, Kantarjian H, Estey E. Yanada M, et al. Among authors: ravandi f. Br J Haematol. 2007 Aug;138(4):555-7. doi: 10.1111/j.1365-2141.2007.06670.x. Epub 2007 Jun 25. Br J Haematol. 2007. PMID: 17593249 Free article. No abstract available.
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study.
Ravandi F, Kantarjian H, Cohen A, Davis M, O'Brien S, Anderlini P, Andersson B, Claxton D, Donato M, Gajewski J, Khouri I, Korbling M, Ueno N, deVos D, Champlin R, Giralt S. Ravandi F, et al. Bone Marrow Transplant. 2001 Jun;27(12):1221-5. doi: 10.1038/sj.bmt.1703028. Bone Marrow Transplant. 2001. PMID: 11548839 Clinical Trial.
Cellular signalling pathways: new targets in leukaemia therapy.
Ravandi F, Talpaz M, Kantarjian H, Estrov Z. Ravandi F, et al. Br J Haematol. 2002 Jan;116(1):57-77. doi: 10.1046/j.1365-2141.2002.03236.x. Br J Haematol. 2002. PMID: 11841398 Free article. Review. No abstract available.
Alemtuzumab.
Ravandi F, O'Brien S. Ravandi F, et al. Expert Rev Anticancer Ther. 2005 Feb;5(1):39-51. doi: 10.1586/14737140.5.1.39. Expert Rev Anticancer Ther. 2005. PMID: 15757437 Review.
Immune defects in patients with chronic lymphocytic leukemia.
Ravandi F, O'Brien S. Ravandi F, et al. Cancer Immunol Immunother. 2006 Feb;55(2):197-209. doi: 10.1007/s00262-005-0015-8. Epub 2005 Jul 16. Cancer Immunol Immunother. 2006. PMID: 16025268 Free PMC article. Review.
862 results